Document Detail


Pseudohallucinations associated with moclobemide: a case report.
MedLine Citation:
PMID:  16025422     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The goal of the multicenter drug surveillance project AMSP ("Arzneimittelsicherheit in der Psychiatrie") is the monitoring, assessment and analysis of adverse drug reactions (ADR) of psychopharmalogical drugs. We report about a 23 year-old patient with a depressive episode. He developed severe pseudohallucinations under a treatment with moclobemide. The symptoms occur 6 days after starting the medication and decline within two days after stopping moclobemide. The term "pseudohallucinations" is discussed controversially but still of high interest.
Authors:
D Degner; S Kropp; J Porzig; R Grohmann; E Rüther
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pharmacopsychiatry     Volume:  38     ISSN:  0176-3679     ISO Abbreviation:  Pharmacopsychiatry     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-07-18     Completed Date:  2005-08-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8402938     Medline TA:  Pharmacopsychiatry     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  179-81     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Psychotherapy, Georg-August University of Göttingen, Germany. ddegner@gwdg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antidepressive Agents / adverse effects*,  therapeutic use
Depressive Disorder / complications,  drug therapy
Hallucinations / chemically induced*,  physiopathology,  psychology
Humans
Male
Mianserin / analogs & derivatives,  therapeutic use
Moclobemide / adverse effects*,  therapeutic use
Monoamine Oxidase Inhibitors / adverse effects*,  therapeutic use
Sertraline / therapeutic use
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/Monoamine Oxidase Inhibitors; 24219-97-4/Mianserin; 61337-67-5/mirtazapine; 71320-77-9/Moclobemide; 79617-96-2/Sertraline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
Next Document:  Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropr...